BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 16116127)

  • 1. Do all young ischemic stroke patients need long-term secondary preventive medication?
    Naess H; Waje-Andreassen U; Thomassen L; Nyland H; Myhr KM
    Neurology; 2005 Aug; 65(4):609-11. PubMed ID: 16116127
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Common genetic markers and prediction of recurrent events after ischemic stroke in young adults.
    Pezzini A; Grassi M; Del Zotto E; Lodigiani C; Ferrazzi P; Spalloni A; Patella R; Giossi A; Volonghi I; Iacoviello L; Magoni M; Rota LL; Rasura M; Padovani A
    Neurology; 2009 Sep; 73(9):717-23. PubMed ID: 19720979
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and radiological recurrence after childhood arterial ischemic stroke.
    Ganesan V; Prengler M; Wade A; Kirkham FJ
    Circulation; 2006 Nov; 114(20):2170-7. PubMed ID: 17075014
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pretreatment with aspirin and etiology of first-ever ischemic stroke in young and middle-aged patients.
    Telman G; Kouperberg E; Sprecher E; Yarnitsky D
    J Neurol Sci; 2009 Jun; 281(1-2):2-5. PubMed ID: 19351569
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recurrent stroke: where do we stand with the secondary prevention of noncardioembolic ischaemic strokes?
    Talelli P; Greenwood RJ
    Ther Adv Cardiovasc Dis; 2008 Oct; 2(5):387-405. PubMed ID: 19124436
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional outcome and prevalence of recurrent ischemic events in patients with acute ischemic stroke due to aortic plaques.
    Baumann CR; Baumgartner RW; von Büdingen HC; Rousson V; Siegel AM; Georgiadis D
    Cerebrovasc Dis; 2007; 24(1):127-9. PubMed ID: 17565198
    [No Abstract]   [Full Text] [Related]  

  • 7. In-hospital initiation of secondary prevention is associated with improved vascular outcomes at 3 months.
    Rahiman A; Saver JL; Porter V; Buxton W; McNair N; Razinia T; Ovbiagele B
    J Stroke Cerebrovasc Dis; 2008; 17(1):5-8. PubMed ID: 18190814
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inpatient and community ischemic strokes in a university hospital.
    Dulli D; Samaniego EA
    Neuroepidemiology; 2007; 28(2):86-92. PubMed ID: 17230028
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aphasia among young patients with ischemic stroke on long-term follow-up.
    Naess H; Hammersvik L; Skeie GO
    J Stroke Cerebrovasc Dis; 2009; 18(4):247-50. PubMed ID: 19560676
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recurrent ischemic events in young adults after first-ever ischemic stroke.
    Putaala J; Haapaniemi E; Metso AJ; Metso TM; Artto V; Kaste M; Tatlisumak T
    Ann Neurol; 2010 Nov; 68(5):661-71. PubMed ID: 21031581
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sildenafil treatment of subacute ischemic stroke: a safety study at 25-mg daily for 2 weeks.
    Silver B; McCarthy S; Lu M; Mitsias P; Russman AN; Katramados A; Morris DC; Lewandowski CA; Chopp M
    J Stroke Cerebrovasc Dis; 2009; 18(5):381-3. PubMed ID: 19717023
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Arterial events after ischemic stroke at a young age: a cross-sectional long-term follow-up of patients and controls in western Norway.
    Waje-Andreassen U; Naess H; Thomassen L; Eide GE; Vedeler CA
    Cerebrovasc Dis; 2007; 24(2-3):277-82. PubMed ID: 17646692
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Standard medical management in secondary prevention of ischemic stroke in China (SMART).
    Peng B; Zhu Y; Cui L; Ni J; Xu W; Zhou L; Yao M; Chen L; Wang J; Wang Y; Pu C;
    Int J Stroke; 2011 Oct; 6(5):461-5. PubMed ID: 21951412
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differentiating ischemic stroke subtypes: risk factors and secondary prevention.
    Kirshner HS
    J Neurol Sci; 2009 Apr; 279(1-2):1-8. PubMed ID: 19185319
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Major vascular events after transient ischaemic attack and minor ischaemic stroke: post hoc modelling of incidence dynamics.
    Atanassova PA; Chalakova NT; Dimitrov BD
    Cerebrovasc Dis; 2008; 25(3):225-33. PubMed ID: 18216464
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antithrombotic and thrombolytic therapy for ischemic stroke.
    Ocava LC; Singh M; Malhotra S; Rosenbaum DM
    Clin Geriatr Med; 2006 Feb; 22(1):135-54, ix-x. PubMed ID: 16377471
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An approach of patients with ischemic stroke to primary and secondary stroke prevention in Poland.
    Nowacki P; Porebska A; Bajer-Czajkowska A; Zywica A; Koziarska D; Podbielski J
    Ann Acad Med Stetin; 2007; 53(2):14-9. PubMed ID: 18557372
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiplatelet and anticoagulant therapy in patients with giant cell arteritis.
    Lee MS; Smith SD; Galor A; Hoffman GS
    Arthritis Rheum; 2006 Oct; 54(10):3306-9. PubMed ID: 17009265
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Causes of ischemic stroke in young adults, and evolution of the etiological diagnosis over the long term.
    Varona JF; Guerra JM; Bermejo F; Molina JA; Gomez de la Cámara A
    Eur Neurol; 2007; 57(4):212-8. PubMed ID: 17268202
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Silent brain infarcts and leukoaraiosis in young adults with first-ever ischemic stroke.
    Putaala J; Kurkinen M; Tarvos V; Salonen O; Kaste M; Tatlisumak T
    Neurology; 2009 May; 72(21):1823-9. PubMed ID: 19470964
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.